Nine Square Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nine Square Therapeutics's estimated annual revenue is currently $2.5M per year.
- Nine Square Therapeutics's estimated revenue per employee is $99,200
- Nine Square Therapeutics's total funding is $4M.
Employee Data
- Nine Square Therapeutics has 25 Employees.
- Nine Square Therapeutics grew their employee count by -4% last year.
Nine Square Therapeutics's People
| Name | Title | Email/Phone |
|---|
Nine Square Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 5 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 4 | -50% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Nine Square Therapeutics?
Nine Square Therapeutics, founded by ATP and leading scientists at UCSF, is discovering and delivering novel small-molecule therapeutics for movement disorders including Parkinson’s, ALS, essential tremors, and dyskinesias. Nine Square applies leading capabilities in computational chemistry, biophysics, and computational biology and a machine-learning-enabled cell profiling platform for target identification, chemical optimization, and patient stratification.
keywords:N/A
$4M
Total Funding
25
Number of Employees
$2.5M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.1M | 25 | -46% | $28M |
#2 | $1.6M | 25 | -44% | $44M |
#3 | $4.4M | 25 | -11% | N/A |
#4 | $4.5M | 25 | -7% | N/A |
#5 | $2.5M | 25 | N/A | N/A |